Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.73 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | MC4R | P32245 | 1/20 | 0.63 |
| ▸ | SLC6A4 | P31645 | 5/20 | 0.54 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 8/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.53 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.53 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | HTR6 | P50406 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3956861 | 1.00 | CYP2D6 (0.73) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| SCHEMBL3950480 | 1.00 | CYP2D6 (0.73) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4813790 | 0.98 | CYP2D6 (0.70) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL17272266 | 0.98 | CYP2D6 (0.70) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4811700 | 0.98 | CYP2D6 (0.70) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL4470172 | 0.98 | CYP2D6 (0.70) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| SCHEMBL30108220 | 0.89 | CHRM2 (0.66) | CYP2D6CHRM2CHRM1MEN1KMT2A | |
| SCHEMBL16226061 | 0.85 | CYP2D6 (1.00) | CYP2D6CHRM2CHRM1MC4ROPRD1 | |
| SCHEMBL6706135 | 0.85 | CYP2D6 (1.00) | CYP2D6CHRM2CHRM1MC4ROPRD1 | |
| SCHEMBL7264542 | 0.85 | CYP2D6 (1.00) | CYP2D6CHRM2CHRM1MC4ROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 634 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119081799-A | Photoresist cleaning solution and preparation method and application thereof | 上海盛剑微电子有限公司 | 2024-12-06 | — | — | CN | claimed |
| US-20200060997-A1 | TARR Receptor Agonists for Sexual Dysfunction | JOHN MCCOY | 2020-02-27 | — | — | US | claimed |
| US-8911775-B2 | pH-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE (KR) | 2014-12-16 | — | — | US | claimed |
| EP-2340811-B1 | Ph-sensitive block copolymer forming polyionic complex micelles and drug or protein carrier using the same | UNIV SUNGKYUNKWAN FOUND (KR) | 2014-10-15 | — | — | EP | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| US-8835492-B2 | Temperature and pH sensitive block copolymer and polymeric hydrogels using the same | SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2014-09-16 | — | — | US | claimed |
| US-8445484-B2 | Bicyclic peptidomimetic inhibitors of aspartyl-proteases for the treatment of infectious diseases | ISTITUTO SUPERIORE DI SANITA' (IT) | 2013-05-21 | — | — | US | claimed |
| US-8383153-B2 | Poly(amidoamine) oligomer hydrogel for drug delivery and drug carrier using the same | SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2013-02-26 | — | — | US | claimed |
| EP-1204677-B1 | CYCLOHEXAPEPTIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A PHARMACEUTICAL | AVENTIS PHARMA GMBH (DE) | 2008-12-03 | — | — | EP | claimed |
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR COROPORATE COLLABORATION (KR) | 2008-11-27 | — | — | US | claimed |
| WO-2008130180-A1 | PREPARATION OF DRUG DELIVERY SYSTEMS USING PH-SENSITIVE BLOCK COPOLYMER AND THEIR APPLICATION | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2008-10-30 | — | — | WO | claimed |
| US-20070218120-A1 | Ph Sensitive Block Copolymer and Polymeric Micelle Using the Same | SUNGKYUNKWAN UNIVERSITY FOUNDATIN FOR CORPORATE COLLOBORATION (KR) | 2007-09-20 | — | — | US | claimed |
| US-7166572-B1 | Cyclohexapeptide compounds, processes for their production and their use as a pharmaceutical | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2007-01-23 | — | — | US | claimed |
| WO-2006109945-A1 | TEMPERATURE AND PH SENSITIVE BLOCK COPOLYMER AND POLYMERIC HYDROGLES USING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2006-10-19 | — | — | WO | claimed |
| WO-2006098547-A1 | PH SENSITIVE BLOCK COPOLYMER AND POLYMERIC MICELLE USING THE SAME | SUNGKYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION (KR) | 2006-09-21 | — | — | WO | claimed |
| EP-1204677-A2 | CYCLOHEXAPEPTIDE COMPOUNDS, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS A PHARMACEUTICAL | Aventis Pharma Deutschland GmbH (DE) | 2002-05-15 | — | — | EP | claimed |
| WO-2001007468-A2 | NOVEL CYCLOHEXAPEPTIDE COMPOUNDS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS A PHARMACEUTICAL | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-02-01 | — | — | WO | claimed |
| EP-0427765-B1 | ALKOXY-4(1H)-PYRIDONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USE AS DRUGS | GOEDECKE AG (DE) | 2000-01-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293827-A1 | Temperature and Ph Sensitive Block Copolymer and Polymeric Hydrogels Using the Same | LRBA, DAO, PAM | CYP2D6 2139/4885CHRM2 2545/4885CHRM1 2148/4885 |
| US-20070218120-A1 | Ph Sensitive Block Copolymer and Polymeric Micelle Using the Same | PAM, DAO, PHYKPL | CYP2D6 1834/4885CHRM2 1422/4885CHRM1 1212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.